Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Older and wiser? The neural correlates of worry induction and reappraisal in older adults
    Published on 2025-09-08
    9 months ago
  • Chronic treatment with fluoxetine regulates mitochondrial features and plasticity-associated transcriptomic pathways in parvalbumin-positive interneurons of prefrontal cortex
    Published on 2025-09-08
    9 months ago
  • Neurodevelopmental considerations for transcranial magnetic stimulation trials in youth
    Published on 2025-09-08
    9 months ago
  • Disentangling the effects of corticotrophin releasing factor and GABA release from the bed nucleus of the stria terminalis on ethanol self-administration in mice
    Published on 2025-09-06
    9 months ago
  • Towards causal inference-based antidepressant selection with brain and blood biomarkers
    Published on 2025-09-05
    9 months ago
  • Progress and opportunity in developmental neurobiology and youth mental health
    Published on 2025-09-05
    9 months ago
  • The Cognitive–Affective Social Processing and Emotion Regulation (CASPER) model
    Published on 2025-09-04
    9 months ago
« Previous 1 … 32 33 34 35 36 … 143 Next »
Journal of Psychopharmacology
  • A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy
    Published on 2024-12-27
    1 year ago
  • Hemispheric annealing and lateralization under psychedelics (HEALS): A novel hypothesis of psychedelic action in the brain
    Published on 2024-12-20
    1 year ago
  • Navigating agitation in neurodevelopmental disorders: A comparative study of pharmacotherapies via network meta-analysis in children and adults with autism spectrum disorder or intellectual disabilities
    Published on 2024-12-18
    1 year ago
  • Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature
    Published on 2024-12-17
    1 year ago
  • Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial
    Published on 2024-12-16
    1 year ago
  • Antipsychotic polypharmacy and high-dose antipsychotic therapy compared to antipsychotic monotherapy at standard doses in schizophrenia – a systematic review
    Published on 2024-12-10
    1 year ago
  • Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis
    Published on 2024-12-10
    1 year ago
« Previous 1 … 32 33 34 35 36 … 146 Next »
European Neuropsychopharmacology
  • Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia
    Published on 2024-12-03
    1 year ago
  • Risk of mortality and complications in people with depressive disorder and diabetes mellitus: A 20-year population-based propensity score-matched cohort study
    Published on 2024-11-30
    1 year ago
  • Rare Genetic variation in schizophrenia: Are the most obvious ‘druggable pathways’ hiding in plain sight?
    Published on 2024-11-29
    1 year ago
  • Valproate’s impact on future generations — A call for stricter guidelines for maternal and paternal use
    Published on 2024-11-29
    1 year ago
  • Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment
    Published on 2024-11-29
    1 year ago
  • Risk of mortality and complications in patients with severe mental illness and co-occurring diabetes mellitus: A systematic review and meta-analysis
    Published on 2024-11-29
    1 year ago
  • Clinical sleep staging for insomnia disorder
    Published on 2024-11-29
    1 year ago
« Previous 1 … 32 33 34 35 36 … 166 Next »

   Pharma Pub